Latest filing published 23 Mar 2026 for PetVivo Holdings, Inc., €22k.
Filing timeline
BuySaleInsider track record
Closed purchases
Based on 8 purchases whose 90-day window has closed (published at least 91 days ago), the same population our ranking model reads.
Purchases by company
Since each purchase
- -66.0%Entry US$2.94 · Close at T+365 US$1.00
- -12.2%Entry US$2.45 · Close at T+365 US$2.15
Entry is the close on the day after publication, the first price a reader could act on. Prices in the listing currency. Past moves are not a forecast.
Robert J. Costantino: trading record in brief
Robert J. Costantino is a declared insider at 3 companies; the most frequent names are PetVivo Holdings, Inc., Cure Pharmaceutical Holding Corp. and Westcorp /CA/. The record holds 15 filings, for trades running from 1 March 2006 to 9 March 2026.
Purchases make up the whole of the open-market record (8 purchases, €23k). A purchase on the market is a deliberate choice to commit personal money, which is why it draws more attention than a grant. Other entries cover 6 share grants.
In size, the median ticket on the buying side is €2,136. Clusters matter here: 8 out of 8 purchases overlapped with buying by a colleague within 30 days. Purchases made close together by different insiders form what is called a cluster. Looking at 8 purchases old enough to measure, the stock rose over the following 90 days in 63% of cases; the median change was +3.7%. This is a record of the past, not a forecast.
The record was last updated on 23 March 2026 with a share grant (€22k) in PetVivo Holdings, Inc. The last insider purchase was made public on 16 March 2023, 1,333 days ago. Typically, a trade is published a median of 2 days after it takes place. Section 16 rules allow two business days to file each Form 4. Source: insider filings from SEC (Form 4). Past trades are no guide to future returns.
Companies and markets linked to Robert J. Costantino
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
- 35,000 shares@ US$0.7452.5% of flowCommon StockSEC:0001493152-26-012229:0
- 12,500 shares@ US$1.2832.3% of flowCommon StockSEC:0001493152-25-018410:0
- 16,458 sharesCommon StockSEC:0001641172-25-022879:0
- 35,000 sharesCommon StockSEC:0001493152-24-046408:0
- 35,000 sharesCommon StockSEC:0001493152-24-041677:0
- 1,000 shares@ US$3.034.8% of flowCommon StockSEC:0001493152-23-007939:1Canonical exit: 13 Jun 2023 (T+90)
- 350 shares@ US$3.041.7% of flowCommon StockSEC:0001493152-23-007939:2Canonical exit: 13 Jun 2023 (T+90)
- 2,000 shares@ US$3.0213.2% of flowCommon StockSEC:0001493152-23-007939:0Canonical exit: 13 Jun 2023 (T+90)
- 226,764 shares0Common StockSEC:0001477932-22-006862:0
- 766 shares@ US$2.463.1% of flowCommon StockSEC:0001493152-22-023426:1Canonical exit: 14 Nov 2022 (T+90)
- 3,000 shares@ US$2.5612.8% of flowCommon StockSEC:0001493152-22-023426:2Canonical exit: 14 Nov 2022 (T+90)
- 234 shares@ US$2.491.0% of flowCommon StockSEC:0001493152-22-023426:3Canonical exit: 14 Nov 2022 (T+90)
- 1,000 shares@ US$2.464.1% of flowCommon StockSEC:0001493152-22-023426:4Canonical exit: 14 Nov 2022 (T+90)
- 353 shares@ US$2.502.0% of flowCommon StockSEC:0001493152-22-023426:0Canonical exit: 14 Nov 2022 (T+90)
- 167 sharesCommon StockSEC:0001209191-06-014978:0
15 of 15 declarations
